News

More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.

Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...

This is the first part of the 14th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by...

Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/

Why it matters: Confusing...

"MC0_8230" via Wikimedia Commons licensed under CC by 2.0 

This report documents a deliberate assault on disabled people in...

By David Masci, Pew Research Center | 07.26.2016

Human enhancement is at least as old as human civilization. People have been trying to enhance their physical and mental...

By Ed Cara, Medical Daily | 07.26.2016

Fond as we are of superheroes on the big screen, most of us would stop short of actually becoming one via...

By Elizabeth Woyke, MIT Technology Review | 07.25.2016

Colon cancer is less common in India than in the U.S., but it tends to affect younger people and...

By Arlene Weintraub, MIT Technology Review | 07.25.2016

At Human Longevity Inc. (HLI) in La Jolla, California, more than two dozen machines work around the clock, sequencing...

By Jocelyn Stried, Margaret Hayden, Rahul Nayajk & Cameron Nutt, STAT | 07.25.2016

In the wake of the brutal killings of Alton Sterling, Philando Castille, Delrawn Small, and police officers in Dallas and...

By Rhiannon Lucy Cosslett, The Guardian | 07.25.2016

The astute woman of child-bearing age develops a facility to tune out of alarmist headlines about the biological clock...

By Chung Hyun-chae, The Korea Times | 07.24.2016

Korea's Center for Disease Control and Prevention (KCDC) has rejected the registration of a stem cell line, dubbed NT-1, created...

By Dara Mohammadi & Nicola Davis, The Guardian | 07.24.2016

Elizabeth Parrish is CEO of BioViva, a Seattle-based biotech company working to develop treatments to slow the ageing process...